Droxidopa and pharmaceutical composition thereof for the treatment of mood disorders, sleep disorders, or attention deficit disorders

Details for Australian Patent Application No. 2008248382 (hide)

Owner Chelsea Therapeutics, Inc.

Inventors Roberts, Michael J.; Pedder, Simon

Agent Fisher Adams Kelly

Pub. Number AU-A-2008248382

PCT Pub. Number WO2008/137923

Priority 60/916,497 07.05.07 US

Filing date 7 May 2008

Wipo publication date 13 November 2008

International Classifications

A61K 31/138 (2006.01) - Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine

A61K 31/195 (2006.01)

A61K 31/198 (2006.01)

A61K 31/275 (2006.01) - Nitriles

A61K 31/345 (2006.01) - Nitrofurans

Event Publications

7 January 2010 PCT application entered the National Phase

  PCT publication WO2008/137923 Priority application(s): WO2008/137923

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008248385-Managing network components using USB keys

2008248373-Methods and apparatus for exposing workflow process definitions as business objects